Optimal Protamine Dosing for Heparin Reversal Following Cardiopulmonary Bypass

Clinical trial NCT05426031 · COMPLETED

Trial details

NCT number: NCT05426031
Sponsor: University of Miami
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Coagulation; Intravascular

Start date: 2022-06-28
Primary completion: 2023-06-01
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.